Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × danvatirsen × Clear all

NCT03527147 2022-08-15

PRISM

Phase 1 Completed

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT02549651 2019-02-27

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse